Subrahmanyeswara Srinivas Samavedi, MD | |
2214 Canterbury Dr Ste 308, Hays, KS 67601-2375 | |
(785) 628-6014 | |
(785) 628-6094 |
Full Name | Subrahmanyeswara Srinivas Samavedi |
---|---|
Gender | Male |
Speciality | Urology |
Experience | 32 Years |
Location | 2214 Canterbury Dr Ste 308, Hays, Kansas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811145212 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | 0440636 (Kansas) | Primary |
208800000X | Urology | 35.096110 (Ohio) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Hays Medical Center | Hays, KS | Hospital |
Citizens Medical Center | Colby, KS | Hospital |
Goodland Regional Medical Center | Goodland, KS | Hospital |
University Of Ks Hlth System Great Bend Campus | Great bend, KS | Hospital |
Norton County Hospital | Norton, KS | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Hays Medical Center Inc | 1557279676 | 158 |
News Archive
Senate aides expect Republicans and Democrats to offer competing amendments to change a tax-reporting provision in the health law. "The provision requires businesses to report to the Internal Revenue Service purchases over the course of the year that exceed $600.
Almost 12,000 people died in alcohol-related vehicle crashes in 2008. About 15,000 Americans died of AIDS-related illness the same year. Both of these preventable causes of death have been the subject of massive, expensive and high-profile interventions by federal and state authorities. CRE encourages expenditures for these programs but the public health community should be even more concerned for greater society-wide risks.
In most cases, prostate cancer is cured by surgical removal of the tumor and/or by radiotherapy. However, 20% of patients will need treatment to remove tumor cells but this treatment ceases to be effective after two or three years and the cancer develops further.
Celsion Corporation, a leading oncology drug development company, today announced financial results for the fourth quarter and year ended December 31, 2009. Management also highlighted the progress made in clinical trials of ThermoDox®, Celsion's heat activated liposomal encapsulation of doxorubicin, including the Company's pivotal Phase III trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer, and recurrent chest wall breast cancer.
› Verified 3 days ago
Entity Name | Hays Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1770618258 PECOS PAC ID: 1557279676 Enrollment ID: O20040224000687 |
News Archive
Senate aides expect Republicans and Democrats to offer competing amendments to change a tax-reporting provision in the health law. "The provision requires businesses to report to the Internal Revenue Service purchases over the course of the year that exceed $600.
Almost 12,000 people died in alcohol-related vehicle crashes in 2008. About 15,000 Americans died of AIDS-related illness the same year. Both of these preventable causes of death have been the subject of massive, expensive and high-profile interventions by federal and state authorities. CRE encourages expenditures for these programs but the public health community should be even more concerned for greater society-wide risks.
In most cases, prostate cancer is cured by surgical removal of the tumor and/or by radiotherapy. However, 20% of patients will need treatment to remove tumor cells but this treatment ceases to be effective after two or three years and the cancer develops further.
Celsion Corporation, a leading oncology drug development company, today announced financial results for the fourth quarter and year ended December 31, 2009. Management also highlighted the progress made in clinical trials of ThermoDox®, Celsion's heat activated liposomal encapsulation of doxorubicin, including the Company's pivotal Phase III trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer, and recurrent chest wall breast cancer.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Subrahmanyeswara Srinivas Samavedi, MD 2214 Canterbury Dr Ste 308, Hays, KS 67601-2375 Ph: (785) 628-6014 | Subrahmanyeswara Srinivas Samavedi, MD 2214 Canterbury Dr Ste 308, Hays, KS 67601-2375 Ph: (785) 628-6014 |
News Archive
Senate aides expect Republicans and Democrats to offer competing amendments to change a tax-reporting provision in the health law. "The provision requires businesses to report to the Internal Revenue Service purchases over the course of the year that exceed $600.
Almost 12,000 people died in alcohol-related vehicle crashes in 2008. About 15,000 Americans died of AIDS-related illness the same year. Both of these preventable causes of death have been the subject of massive, expensive and high-profile interventions by federal and state authorities. CRE encourages expenditures for these programs but the public health community should be even more concerned for greater society-wide risks.
In most cases, prostate cancer is cured by surgical removal of the tumor and/or by radiotherapy. However, 20% of patients will need treatment to remove tumor cells but this treatment ceases to be effective after two or three years and the cancer develops further.
Celsion Corporation, a leading oncology drug development company, today announced financial results for the fourth quarter and year ended December 31, 2009. Management also highlighted the progress made in clinical trials of ThermoDox®, Celsion's heat activated liposomal encapsulation of doxorubicin, including the Company's pivotal Phase III trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer, and recurrent chest wall breast cancer.
› Verified 3 days ago
Darrell D Werth, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 2214 Canterbury Dr, Suite 308, Hays, KS 67601 Phone: 785-628-6014 Fax: 785-628-6094 | |
Dr. Kevin R Mcdonald, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2214 Canterbury Dr, Suite 308, Hays, KS 67601 Phone: 785-628-6014 Fax: 785-628-6094 | |
Faris Sabri Azzouni, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2214 Canterbury Dr, Suite 308, Hays, KS 67601 Phone: 785-628-6014 Fax: 785-628-6094 | |
Ernesto Lopez-corona, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2214 Canterbury Dr, Suite 308, Hays, KS 67601 Phone: 785-628-6014 Fax: 785-628-6094 |